NIOX Group Plc (CSSPF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ian Roy Johnson | Executive Chairman | 842.9k | -- | 1953 |
| Mr. Jonathan Emms | CEO & Executive Director | 846.88k | -- | 1963 |
| Mr. Michael Roy David Roller A.C.A., BA (Hons) | CFO & Director | 473.88k | -- | 1965 |
| Mr. Tom Scaccia | Senior Vice President of Americas & Research Business | -- | -- | -- |
| Ms. Sarah Elizabeth Duncan | Group Financial Controller & Company Secretary | -- | -- | -- |
NIOX Group Plc
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 91
Description
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Corporate Governance
Upcoming Events
April 1, 2025 at 6:00 AM UTC
NIOX Group Plc Earnings Date
May 15, 2025 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available